Abstract:Glutathione S-transferase π-1 (GSTP-1) is a member of the glutathione S-transferase enzyme superfamily, which catalyzes the conjugation of electrophiles to glutathione during the process of detoxification. In this study, the epigenetic alterations of GSTP-1 expression in human colorectal cancers and the underlying mechanisms were investigated. In 10 colon cancer patients, proteomic analysis revealed that expression of GSTP-1 protein was higher in tumor tissues than in paired adjacent normal tissues. Likewise, in 7 of 10 colon cancer patients, GSTP-1 protein expression was more than 1.5-fold higher in tumor tissues than in adjacent normal tissues, as determined by western blotting. Immunohistochemical data confirmed that GSTP-1 protein was expressed at higher levels in colon cancer tissues compared to normal mucosa. GSTP-1 enzyme activity was closely correlated with GSTP-1 protein expression in colon cancer patients. Consistent with this, GSTP-1 mRNA, protein and activity levels were higher in the colorectal cancer cell lines Caco-2, HCT-116, HT-29, SNU-407 and SNU-1033 compared to the normal colon cell line FHC. Methylation-specific PCR results indicated that the high levels of GSTP-1 in human colorectal cancer cell lines were likely due to the lower degree of promoter methylation in colon cancer cell lines compared to the normal colon cell line, consistent with findings in colon cancer patients. Moreover, the levels of specific activator-protein complexes and histone marks were higher in human colorectal cancer cells compared to the normal human colon cell line, whereas the repressor protein complexes exhibited the opposite pattern. Furthermore, chromatin immunoprecipitation assays demonstrated that expression levels of the transcription factors AP-1 and SP-1 were correlated with the upregulation of GSTP-1 expression in colorectal cancer cells. Finally, knockdown of GSTP-1 promoted the sensitivity of SNU-407 cells to the anticancer agent 5-fluorouracil. These data indicate that GSTP-1 may serve as a clinically useful biomarker of colon cancer and a target for anti-colon cancer drugs.

[Expression of Glutathione S-transferase-pi and DNA Topoisomerase II Alpha and Their Implications in Colorectal Carcinoma].

Expression and clinical significance of TopoⅡand GST-πin gastric and colorectal car-cinoma

Expressions and Significances of Topoisomeraseⅱ and Multidrug Resistance-Associated Protein in Human Esophageal Squamous Cell Carcinoma

Expression of ToPo Ⅱ,MRP,GST-π in Gastric Carcinoma and Its Relationship with Prognosis

Expression of P-glycoprotein, topoisomerase II and glutathione S-transferase π in gastric carcinoma and their correlations with clinical prognosis

The Expression of P-gp, GST-π and Topo II in Breast Carcinoma and Its Clinical Significance

The Expression and Clinical Significance of P-gp, GST-π in Colorectal Carcinoma

Ultrastructural Localization of Glutathione S-transferase-pi in Human Colorectal Cancer Cells.

The Association Between Chemosensitivity And Pgp, Gst-Pi And Topo Ii Expression In Gastric Cancer

Expression of Glutathione-S-transferase Π in Colorectal Carcinoma and the Relation with Its Plasma Levels

Expression and Clinical Significance of Lung Resistance Protein, P- Giycoprotein, Glutathione-S-transferase-π and Topoisomeraseii in Lung Cancer

Expression and Significance of Topoisomerase Ⅱα in Colorectal Caner

Study on the Expressions of Pgp,GST-π,Topo II and Their Relationship with P16 and P53 in Gastric Carcinoma

Expressions of p53 and hMSH2 in colon carcinoma

Expression of glutathione S-transferase in colorectal mucinous adenocarcinoma and its clinical significance

Expression of Topo IIα and P-glycoprotein in Gallbladder Carcinoma and Their Clinical Significance

DNA Topoisomerase II Alpha: a Favorable Prognostic Factor in Colorectal Caner

Expression of multidrug resistance-related proteins MRP1/MRP2/LRP/Topo Ⅱ/GST-π in carcinoma of callbladder and cholangiocarcinoma

[Relation Between the Expression of P-gp and GST-pi in Oral and Maxillofacial Squamous Carcinoma and Chemoresistance].

Epigenetic alterations are involved in the overexpression of glutathione S-transferase π-1 in human colorectal cancers.

Expression and clinical significance of multidrug resistance associated protein-1 and DNA topoisomerase-Ⅱ